Navigation Links
Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
Date:5/28/2013

NEW YORK, May 28, 2013 /PRNewswire/ -- Omthera Pharmaceuticals and AstraZeneca announced today that the companies entered into a merger agreement under which AstraZeneca will acquire all of the outstanding stock of Omthera for an upfront payment of $12.70 in cash per share, approximately $323 million aggregate value ($260 million after subtracting cash), plus a contingent value right for up to $4.70 per share, equaling approximately $120 million and for a total value of up to $443 million. Covington & Burling LLP advised Omthera on the transaction.

Omthera is an emerging specialty pharmaceutical company led by a team of experts with exceptional experience in developing new therapies for lipid disorders. Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease. AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.

The Covington team was led by corporate partner Scott Smith and corporate associate Matthew Fox, with the assistance of associates Patrick Manchester, Peter Kim and Aisha Granville.  Also advising on the transaction were partner Jim Snipes (life sciences commercial), partner Mike Lefever and associate Erik Durbin (securities), partner Seth Safra and counsel Kendra Roberson (benefits), partner Mike Labson and associates Afia Asamoah and Noellyn Davies (food & drug regulatory), partner James O'Connell and associate James Burke (antitrust), and partner Rob Heller and associate Sarah Burnham (tax).

Covington & Burling LLP, an international law firm, provides corporate, litigation, and regulatory expertise to enable clients to achieve their goals.  Founded in 1919, the firm has more than 800 lawyers and offices in Beijing, Brussels, London, New York, San Diego, San Francisco, Seoul, Shanghai, Silicon Valley, and Washington, DC.

Contact: An Pham
+1.202.662.6575
apham@cov.com


'/>"/>
SOURCE Covington & Burling LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises
2. Addressing Hearing Loss Proves Win-Win for Both Employer and Employee, BHI Advises During National Employee Wellness Month
3. Underage Kids Get Hydrocodone Drugs Easily from Family & Friends, Advises New York Center for Living
4. Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
5. Apex BioStrategists Advises On Flow Cytometry Sale To Coulter
6. Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
7. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
8. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
9. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
10. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... SmartLinx, a leader in workforce ... that further engages healthcare employees by enabling them to take control of their schedules ... show up to work and do more work -- highly engaged business units realize ...
(Date:7/17/2019)... ... July 17, 2019 , ... Argos Risk, ... expansion into the healthcare sector during the second quarter of 2019. Three nationwide ... management join a strong client list in managing and mitigating third-party risk. ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... For the second year in a row, ... This award was given by the Orange County Business Journal, which is the second largest ... award in Orange County, with the additional honor of ranking third place in the medium ...
Breaking Medicine Technology:
(Date:7/12/2019)... ... July 12, 2019 , ... Rebecca Baxt, M.D., F.A.A.D. ... NJ Top Docs for 2019. Located in Paramus, BAXT CosMedical is a renowned facility ... and medical dermatological care for the past 45 years. , NJ Top Docs, Dr. ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... industry sector and chaired by the American Bakers Association (ABA), testified today on ... Committee (DGAC) meeting. The recommendations in the Committee’s scientific report, due next year, ...
(Date:7/10/2019)... (PRWEB) , ... July 10, 2019 , ... HMP, a ... an official partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 ... Journal of Clinical Pathways and focuses on the expansion of clinical pathways as a ...
(Date:7/9/2019)... ... July 10, 2019 , ... Women’s Excellence is pleased to ... This blog covers a variety of topics including women’s health information, current events, advancements ... are passionate about women’s healthcare and we’re excited to offer a new women’s health ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... at the Association of American Cancer Institutes – Clinical Research Innovation (AACI-CRI) annual ... design, activation, management and data analysis. As the leading provider of clinical research ...
Breaking Medicine News(10 mins):